A psychopharmacologist's perspective on panic disorder
Related Experiment Video
Updated: Oct 22, 2026

Using the Threat Probability Task to Assess Anxiety and Fear During Uncertain and Certain Threat
Published on: September 12, 2014
1Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston 02114.
Abstract:
In the "medical model" view of panic disorder, essential concepts are (1) constitutional vulnerability to disorder and (2) the unique "pathogenic" propensity of a panic attack to generate an array of biobehavioral complications. The normal fear-security system is activated at low threshold or is vulnerable to dysregulation, a vulnerability that is triggered by life events and modified through developmental experience. The author describes the current medical model of panic disorder and then reviews psychopharmacological treatment options and their advantages and disadvantages.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Theoretical Approaches to Psychological Disorder
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
Panic Disorder
Drug Therapy
Antianxiety Medications

